BeOne Medicines Ltd. (ONC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$15.76M2015: -$56.74M2016: -$117.06M2017: -$98.46M2018: -$705.77M2019: -$959.89M2020: -$1.66B2021: -$1.44B2022: -$1.79B2023: -$1.21B2024: -$568.20M2025: $447.14M$447.14M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$447.14M+178.7%
2024-$568.20M+53.0%
2023-$1.21B+32.5%
2022-$1.79B-24.4%
2021-$1.44B+13.2%
2020-$1.66B-72.7%
2019-$959.89M-36.0%
2018-$705.77M-616.8%
2017-$98.46M+15.9%
2016-$117.06M-106.3%
2015-$56.74M-260.1%
2014-$15.76M